The Department of Veterans Affairs and Sioux Falls, S.D.-based Sanford Health will provide free pharmacogenetic testing to veterans through a partnership to improve care and lower costs related to adverse reactions to medications. Sanford Health and philanthropist Denny Sanford will provide $25 million each to fund the PHASeR initiative, which will initially enroll cancer survivors and expand by 2022 to include up to 250,000 veterans at 125 sites and pharmaceutical treatments for mental health, cardiovascular disease and pain management, the partners said. Veterans will access the testing at their local VA facility, beginning at a pilot site in Durham, N.C. Sanford Health will process the tests at its South Dakota-based Imagenetics facility and share the results with the patients’ physicians through the electronic health record to help in choosing treatments. More than 90 percent of patients tested at the facility carry a genetic change that could affect medication selection or dosing, the health system said.

Related News Articles

Headline
Commenting yesterday on the proposed rule for the Department of Veterans Affairs’ Veterans Community Care Program, AHA said the rule “will provide continuity…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.
Headline
The Department of Veterans Affairs today proposed the criteria for determining when covered veterans may elect to receive necessary hospital, medic
Headline
The Department of Veterans Affairs today published a proposed rule implementing urgent care provisions of the AHA-supported MISSION Act of 2018, which requires…
Headline
The Department of Veterans Affairs today announced its proposed access standards for the new Veterans Community Care Program to begin in June under the AHA-…
Headline
The Department of Veterans Affairs recently awarded contracts to manage provider networks in three regions of the country as part of its roll out of the new VA…